痛風と慢性腎臓病の患者の腎機能に対するアルロプリノールの影響
Ana Beatriz Vargas-Santos1, Christine E Peloquin2, Tuhina Neogi2
1Rheumatology Unit, Hospital Universitário Pedro Ernesto, Universidade do Estado do Rio de Janeiro, Rio de Janeiro 20551-030, RJ, Brazil.
まとめ
痛風と慢性腎臓病 (CKD) の患者におけるアルロプリノールの使用は腎機能を悪化させなかった. この研究では,アルロピュリノールが腎臓機能を軽く改善することが示唆されています.
科学分野:
- 腎臓科
- リウマトロジ
- 薬理学について
背景:
- 痛風患者におけるアルロピュリノールの腎臓への影響については,矛盾する証拠がある.
- 慢性腎臓病 (CKD) の患者にアルロプリノールを処方することを医師はしばしば躊躇する.
研究 の 目的:
- アロプリノールの使用と腎機能の変化の関連性を,痛風とCKDの3~4段階の患者で調査する.
- アロプリノールが腎臓機能に害があるかどうかを判断する.
主な方法:
- イギリスの一般的な人口データを用いて,時間階層化傾向スコア (PS) にマッチしたコホート研究が行われました.
- アロピュリノールを新たに摂取した10716人の痛風とCKD3−4患者は,使用しない患者と1対1で比較された.
- 調整された線形回帰を用いて,1年後の推定グルメル濾過率 (eGFR) の変化を分析した.
主要な成果:
- アロプリノールを投与した患者は,非投与者と比較して平均EGFR増加が0. 81mL/ minであった.
- 透析や腎臓移植への進行は,アロピュリノールと非使用者群の間で類似した.
- アロプリノールによる腎機能の悪化の証拠は認められなかった.
結論:
- アロプリノールの使用は,痛風およびCKDの第3〜4段階の患者では,腎機能の悪化と関連していません.
- アロプリノールは,この患者群で腎機能にわずかな有益な効果がある可能性があります.
- アロプリノールは痛風とCKDの患者に安全に使用できると示唆されています.
関連する概念動画
Factors Affecting Renal Clearance: Renal Impairment
157
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
157
Renal Failure: Dose Adjustments
153
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
153
Chronic Kidney Disease II: Clinical Manifestations
87
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
87
Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
Chronic Kidney Disease I: Introduction
67
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
67
Chronic Kidney Disease IV: Nursing Management
55
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
55


